JP2020506884A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020506884A5 JP2020506884A5 JP2019534124A JP2019534124A JP2020506884A5 JP 2020506884 A5 JP2020506884 A5 JP 2020506884A5 JP 2019534124 A JP2019534124 A JP 2019534124A JP 2019534124 A JP2019534124 A JP 2019534124A JP 2020506884 A5 JP2020506884 A5 JP 2020506884A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cancer
- group
- compound according
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022162614A JP2023011613A (ja) | 2016-12-23 | 2022-10-07 | 血管新生および／またはリンパ脈管新生関連の疾病の処置のためのｓｏｘ１８タンパク質活性の阻害剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2016905362A AU2016905362A0 (en) | 2016-12-23 | Compounds and use thereof in methods of treatment | |
| AU2016905362 | 2016-12-23 | ||
| PCT/AU2017/051439 WO2018112545A1 (en) | 2016-12-23 | 2017-12-21 | Inhibitors of sox18 protein activity for treating angiogenesis- and/or lymphangiogenesis-related diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022162614A Division JP2023011613A (ja) | 2016-12-23 | 2022-10-07 | 血管新生および／またはリンパ脈管新生関連の疾病の処置のためのｓｏｘ１８タンパク質活性の阻害剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020506884A JP2020506884A (ja) | 2020-03-05 |
| JP2020506884A5 true JP2020506884A5 (enExample) | 2021-01-28 |
| JP7579057B2 JP7579057B2 (ja) | 2024-11-07 |
Family
ID=62624141
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019534124A Active JP7579057B2 (ja) | 2016-12-23 | 2017-12-21 | 血管新生および／またはリンパ脈管新生関連の疾病の処置のためのｓｏｘ１８タンパク質活性の阻害剤 |
| JP2022162614A Pending JP2023011613A (ja) | 2016-12-23 | 2022-10-07 | 血管新生および／またはリンパ脈管新生関連の疾病の処置のためのｓｏｘ１８タンパク質活性の阻害剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022162614A Pending JP2023011613A (ja) | 2016-12-23 | 2022-10-07 | 血管新生および／またはリンパ脈管新生関連の疾病の処置のためのｓｏｘ１８タンパク質活性の阻害剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US11434190B2 (enExample) |
| EP (1) | EP3558293A4 (enExample) |
| JP (2) | JP7579057B2 (enExample) |
| KR (1) | KR102572077B1 (enExample) |
| CN (1) | CN110536685A (enExample) |
| AU (1) | AU2017383102B2 (enExample) |
| CA (1) | CA3048040A1 (enExample) |
| WO (1) | WO2018112545A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110536685A (zh) | 2016-12-23 | 2019-12-03 | 昆士兰大学 | Sox18蛋白活性的抑制剂用于治疗血管生成相关疾病和/或淋巴管生成相关疾病 |
| CN110143941B (zh) * | 2019-06-04 | 2021-05-25 | 北京四环制药有限公司 | 一种巴罗萨韦玛波酯中间体的合成方法 |
| CA3190768A1 (en) * | 2020-08-26 | 2022-03-03 | Mathias Frederic FRANCOIS | Antiviral sox inhibitors |
| CN118834915A (zh) * | 2024-08-15 | 2024-10-25 | 扬州大学 | 一种在羊毛乳头细胞中稳定过表达的sox18慢病毒重组标签载体的构建及应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01503303A (ja) | 1987-05-19 | 1989-11-09 | フアイソンズ・ピーエルシー | 化合物 |
| US6326507B1 (en) * | 1998-06-19 | 2001-12-04 | Trustees Of Dartmouth College | Therapeutic compounds and methods of use |
| DE10015525A1 (de) | 2000-03-30 | 2001-10-11 | Deutsches Krebsforsch | Synthetische Derivate von Lunularsäure, Arzneimittel enthaltend diese Verbindung, Verfahren zur Herstellung der Lunularsäurederivate sowie deren Verwendung |
| CA2528669A1 (en) * | 2003-06-09 | 2005-01-20 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
| ITRM20030355A1 (it) | 2003-07-18 | 2005-01-19 | Sigma Tau Ind Farmaceuti | Composti ad attivita' citotossica derivati della combretastatina. |
| UA94724C2 (en) * | 2005-12-08 | 2011-06-10 | Новартис Аг | Thiadiazolidinone derivatives as antidiabetic agents |
| CN101062043B (zh) | 2006-04-30 | 2011-06-08 | 浙江天皇药业有限公司 | 3,4,5,4'-四甲氧基二苯乙烷-3’-o-磷酸二钠在抗肿瘤及其转移药物的应用 |
| CN101235003B (zh) | 2007-02-01 | 2010-09-15 | 浙江赛尔生物医学研究有限公司 | 3,4,5,4'-四甲氧基-α,β-二苯乙烷-3'-O-硫酸酯钠盐及其应用 |
| JP2012505185A (ja) * | 2008-10-13 | 2012-03-01 | ノバルティス アーゲー | ファルネシルピロホスフェートシンターゼ活性阻害剤であるサリチル酸誘導体 |
| CA2794266C (en) * | 2010-03-24 | 2020-09-08 | Ohio University | Compositions and methods for glucose transport inhibition |
| CN102050759A (zh) | 2010-12-09 | 2011-05-11 | 江苏天晟药业有限公司 | 白藜芦醇酰胺类衍生物及其制备方法 |
| US9834575B2 (en) | 2013-02-26 | 2017-12-05 | Triact Therapeutics, Inc. | Cancer therapy |
| WO2015061779A1 (en) * | 2013-10-25 | 2015-04-30 | Wayne State University | Methods, systems and compositions relating to cell conversion via protein induced in-vivo cell reprogramming |
| CN110536685A (zh) * | 2016-12-23 | 2019-12-03 | 昆士兰大学 | Sox18蛋白活性的抑制剂用于治疗血管生成相关疾病和/或淋巴管生成相关疾病 |
| CA3190768A1 (en) * | 2020-08-26 | 2022-03-03 | Mathias Frederic FRANCOIS | Antiviral sox inhibitors |
-
2017
- 2017-12-21 CN CN201780086511.1A patent/CN110536685A/zh active Pending
- 2017-12-21 KR KR1020197021576A patent/KR102572077B1/ko active Active
- 2017-12-21 US US16/472,882 patent/US11434190B2/en active Active
- 2017-12-21 AU AU2017383102A patent/AU2017383102B2/en active Active
- 2017-12-21 WO PCT/AU2017/051439 patent/WO2018112545A1/en not_active Ceased
- 2017-12-21 JP JP2019534124A patent/JP7579057B2/ja active Active
- 2017-12-21 CA CA3048040A patent/CA3048040A1/en active Pending
- 2017-12-21 EP EP17884538.4A patent/EP3558293A4/en active Pending
-
2022
- 2022-05-10 US US17/741,065 patent/US20230100768A1/en active Pending
- 2022-10-07 JP JP2022162614A patent/JP2023011613A/ja active Pending
-
2023
- 2023-06-27 US US18/342,312 patent/US12410116B2/en active Active